The DOI matches its Crossref record; 41 of the 41 references it cites were found in a registry or an index.
Small Cell and Large Cell Neuroendocrine Carcinomas of the Pancreas are Genetically Similar and Distinct From Well-differentiated Pancreatic Neuroendocrine Tumors
Open accessAbstract
Poorly differentiated neuroendocrine carcinomas (NECs) of the pancreas are rare malignant neoplasms with a poor prognosis. The aim of this study was to determine the clinicopathologic and genetic features of poorly differentiated NECs and compare them with other types of pancreatic neoplasms. We investigated alterations of KRAS, CDKN2A/p16, TP53, SMAD4/DPC4, DAXX, ATRX, PTEN, Bcl2, and RB1 by immunohistochemistry and/or targeted exomic sequencing in surgically resected specimens of 9 small cell NECs, 10 large cell NECs, and 11 well-differentiated neuroendocrine tumors (PanNETs) of the pancreas. Abnormal immunolabeling patterns of p53 and Rb were frequent (p53, 18 of 19, 95%; Rb, 14 of 19, 74%) in both small cell and large cell NECs, whereas Smad4/Dpc4, DAXX, and ATRX labeling was intact in virtually all of these same carcinomas. Abnormal immunolabeling of p53 and Rb proteins correlated with intragenic mutations in the TP53 and RB1 genes. In contrast, DAXX and ATRX labeling was lost in 45% of PanNETs, whereas p53 and Rb immunolabeling was intact in these same cases. Overexpression of Bcl-2 protein was observed in all 9 small cell NECs (100%) and in 5 of 10 (50%) large cell NECs compared with only 2 of 11 (18%) PanNETs. Bcl-2 overexpression was significantly correlated with higher mitotic rate and Ki67 labeling index in neoplasms in which it was present. Small cell NECs are genetically similar to large cell NECs, and these genetic changes are distinct from those reported in PanNETs. The finding of Bcl-2 overexpression in poorly differentiated NECs, particularly small cell NEC, suggests that Bcl-2 antagonists/inhibitors may be a viable treatment option for these patients.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
WHO Classification of Tumours of the Digestive System
Bosman, F. T. (2010) · Medical Entomology and Zoology · Cited by 5,041
Yao, J. C., Hassan, M., Phan, A., Dagohoy, C., Leary, C., Mares, J. E., Abdalla, E. K., Fleming, J. B., Vauthey, J.-N., Rashid, A., et al. (2008) · Journal of Clinical Oncology · doi:10.1200/jco.2007.15.4377 · Cited by 4,510
Distant metastasis occurs late during the genetic evolution of pancreatic cancer
Yachida, S., Jones, S., Bozic, I., Antal, T., Leary, R., Fu, B., Kamiyama, M., Hruban, R. H., Eshleman, J. R., Nowak, M. A., et al. (2010) · Nature · doi:10.1038/nature09515 · Cited by 2,502
Self-citationPathology and genetics of tumours of the lung , pleura, thymus and heart
Travis, W. D. (2004) · Cited by 1,955
Jiao, Y., Shi, C., Edil, B. H., de Wilde, R. F., Klimstra, D. S., Maitra, A., Schulick, R. D., Tang, L. H., Wolfgang, C. L., Choti, M. A., et al. (2011) · Science · doi:10.1126/science.1200609 · Cited by 1,717
Self-citationGenetics and biology of pancreatic ductal adenocarcinoma
Hezel, A. F., Kimmelman, A. C., Stanger, B. Z., Bardeesy, N., & DePinho, R. A. (2006) · Genes & Development · doi:10.1101/gad.1415606 · Cited by 1,577
Noda, K., Nishiwaki, Y., Kawahara, M., Negoro, S., Sugiura, T., Yokoyama, A., Fukuoka, M., Mori, K., Watanabe, K., Tamura, T., et al. (2002) · New England Journal of Medicine · doi:10.1056/nejmoa003034 · Cited by 1,371
Progression model for pancreatic cancer.
Hruban, R. H., Goggins, M., Parsons, J., & Kern, S. E. (2000) · PubMed · Cited by 1,102
Self-citationIacobuzio-Donahue, C. A., Fu, B., Yachida, S., Luo, M., Abe, H., Henderson, C. M., Vilardell, F., Wang, Z., Keller, J. W., Banerjee, P., et al. (2009) · Journal of Clinical Oncology · doi:10.1200/jco.2008.17.7188 · Cited by 1,081 · cited 1×
“The molecular abnormalities and median survival of small cell NEC, large cell NEC, well-differentiated PanNET, PDAC, and small cell lung carcinoma are summarized in Table 5, based on the current study and previously published reports that include our own work.(4,9,10,15,18,29,34,37,51,55) There is no consensus on the…”
BackgroundSelf-citationKlimstra, D. S., Modlin, I. R., Coppola, D., Lloyd, R. V., & Suster, S. (2010) · Pancreas · doi:10.1097/mpa.0b013e3181ec124e · Cited by 1,072
Self-citationBcl-2 Inhibitors: Targeting Mitochondrial Apoptotic Pathways in Cancer Therapy
Kang, M. H., & Reynolds, C. P. (2009) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-08-0144 · Cited by 1,016
Meuwissen, R., Linn, S. C., Linnoila, R. I., Zevenhoven, J., Mooi, W. J., & Berns, A. (2003) · Cancer Cell · doi:10.1016/s1535-6108(03)00220-4 · Cited by 643 · cited 1×
“Interestingly, in mouse models of human small cell lung carcinoma, Cre-mediated deletion of RB1 and TP53 conditional alleles in the lungs of adult mice results in the development of tumors that share many characteristics with human small cell lung carcinoma, including their histopathology, the expression of neuroendoc…”
BackgroundMinna, J. D., Roth, J. A., & Gazdar, A. F. (2002) · Cancer Cell · doi:10.1016/s1535-6108(02)00027-2 · Cited by 549
Lara, P. N., Natale, R., Crowley, J., Lenz, H. J., Redman, M. W., Carleton, J. E., Jett, J., Langer, C. J., Kuebler, J. P., Dakhil, S. R., et al. (2009) · Journal of Clinical Oncology · doi:10.1200/jco.2008.20.1061 · Cited by 525
Baas, I. O., Mulder, J. R., Offerhaus, G. J. A., Vogelstein, B., & Hamilton, S. R. (1994) · The Journal of Pathology · doi:10.1002/path.1711720104 · Cited by 505
Sjogren, S., Inganas, M., Norberg, T., Lindgren, A., Nordgren, H., Holmberg, L., & Bergh, J. (1996) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/88.3-4.173 · Cited by 381
Hruban, R. H., Pitman, M. B., & Klimstra, D. S. (2007) · American Registry of PathologyWashington, DC eBooks · doi:10.55418/9781933477022 · Cited by 370
Self-citationEkeblad, S., Skogseid, B., Dunder, K., Öberg, K., & Eriksson, B. (2008) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-08-0734 · Cited by 360
Dynamic regulation of Pdx1 enhancers by Foxa1 and Foxa2 is essential for pancreas development
Gao, N., LeLay, J., Vatamaniuk, M. Z., Rieck, S., Friedman, J. R., & Kaestner, K. H. (2008) · Genes & Development · doi:10.1101/gad.1752608 · Cited by 303
The p16INK4a-RB pathway : molecular link between cellular senescence and tumor suppression
Ohtani, N., Yamakoshi, K., Takahashi, A., & Hara, E. (2004) · The Journal of Medical Investigation · doi:10.2152/jmi.51.146 · Cited by 276 · cited 1×
“Moreover, loss of Rb protein was mutually exclusive with loss of p16 protein, in keeping with the close relationship of these protein products in cell cycle regulation.(41) Sequencing analyses of poorly differentiated NECs indicated that intragenic mutation is the major mechanism underlying loss of p53 and Rb protein…”
ResultSomatic in vivo alterations of the DPC4 gene at 18q21 in human lung cancers.
Nagatake, M., Takagi, Y., Osada, H., Uchida, K., Mitsudomi, T., Saji, S., Shimokata, K., Takahashi, T., & Takahashi, T. (1996) · PubMed · Cited by 241
Fisher, T. C., Milner, A. E., Gregory, C. D., Jackman, A. L., Aherne, G. W., Hartley, J. A., Dive, C., & Hickman, J. A. (1993) · PubMed · Cited by 236
Apoptosis in cancer: cause and cure
Kaufmann, S. H., & Gores, G. J. (2000) · BioEssays · doi:10.1002/1521-1878(200011)22:11<1007::aid-bies7>3.0.co;2-4 · Cited by 214
Sartorius, U. A., & Krammer, P. H. (2002) · International Journal of Cancer · doi:10.1002/ijc.10096 · Cited by 207
Zhou, X.-P., Loukola, A., Salovaara, R., Nystrom-Lahti, M., Peltomäki, P., de la Chapelle, A., Aaltonen, L. A., & Eng, C. (2002) · The American Journal of Pathology · doi:10.1016/s0002-9440(10)64200-9 · Cited by 185
Oliver-Krasinski, J. M., Kasner, M. T., Yang, J., Crutchlow, M. F., Rustgi, A. K., Kaestner, K. H., & Stoffers, D. A. (2009) · Journal of Clinical Investigation · doi:10.1172/jci37028 · Cited by 177
Iwasa, S., Morizane, C., Okusaka, T., Ueno, H., Ikeda, M., Kondo, S., Tanaka, T., Nakachi, K., Mitsunaga, S., Kojima, Y., et al. (2010) · Japanese Journal of Clinical Oncology · doi:10.1093/jjco/hyp173 · Cited by 170
Kaye, F. J. (2002) · Oncogene · doi:10.1038/sj.onc.1205834 · Cited by 153 · cited 1×
“Thus, combined loss of p53 and Rb function appears to be a necessary step for the development of this tumor, and alterations of the RB1 gene may play an important role in terms of manifestation of neuroendocrine features.(6,24,26) Interestingly, overexpression of Bcl-2 protein was observed in all 9 small cell NECs and…”
BackgroundHigh-Grade Neuroendocrine Carcinoma of the Ampulla of Vater
Nassar, H., Albores‐Saavedra, J., & Klimstra, D. S. (2005) · The American Journal of Surgical Pathology · doi:10.1097/01.pas.0000157974.05397.4f · Cited by 118
Self-citationBcl-2 protein expression in lung cancer and close correlation with neuroendocrine differentiation.
Jiang, S. X., Kameya, T., Sato, Y., Yanase, N., Yoshimura, H., & Kodama, T. (1996) · Europe PMC (PubMed Central) · Cited by 93
Cagle, P. T., El‐Naggar, A. K., Xu, H., Hu, S., & Benedict, W. F. (1997) · Europe PMC (PubMed Central) · Cited by 92
Rb family proteins differentially regulate distinct cell lineages during epithelial development
Wikenheiser‐Brokamp, K. A. (2004) · Development · doi:10.1242/dev.01232 · Cited by 90
p16INK4a is a Prognostic Marker in Resected Ductal Pancreatic Cancer
Gerdes, B., Ramaswamy, A., Ziegler, A., Lang, S. A., Kersting, M., Baumann, R., Wild, A., Moll, R., Rothmund, Μ., & Bartsch, D. K. (2002) · Annals of Surgery · doi:10.1097/00000658-200201000-00007 · Cited by 89
Paik, P. K., Rudin, C. M., Brown, A. B., Rizvi, N. A., Takebe, N., Travis, W. D., James, L. P., Ginsberg, M. S., Juergens, R. A., Markus, S., et al. (2010) · Cancer Chemotherapy and Pharmacology · doi:10.1007/s00280-010-1265-5 · Cited by 81
Surgical treatment of non‐functioning pancreatic islet cell tumors
Kouvaraki, M. A., Solórzano, C. C., Shapiro, S. E., Yao, J. C., Perrier, N. D., Lee, J. E., & Evans, D. B. (2005) · Journal of Surgical Oncology · doi:10.1002/jso.20178 · Cited by 72
Pdx1 Expression in Pancreatic Precursor Lesions and Neoplasms
Park, J. Y., Hong, S., Klimstra, D. S., Goggins, M., Maitra, A., & Hruban, R. H. (2011) · Applied immunohistochemistry & molecular morphology · doi:10.1097/pai.0b013e318206d958 · Cited by 64
Self-citationClinical significance of p53 functional loss in squamous cell carcinoma of the oropharynx
Obata, A., Eura, M., Sasaki, J., Saya, H., Chikamatsu, K., Tada, M., Iggo, R. D., & Yumoto, E. (2000) · International Journal of Cancer · doi:10.1002/(sici)1097-0215(20000320)89:2<187::aid-ijc14>3.0.co;2-v · Cited by 58
Melhem, M. F., Law, J. C., El-Ashmawy, L., Johnson, J. T., Landreneau, R. J., Srivastava, S., & Whiteside, T. L. (1995) · Europe PMC (PubMed Central) · Cited by 56
Kitamura, H., Yazawa, T., Sato, H., Okudela, K., & Shimoyamada, H. (2009) · Endocrine Pathology · doi:10.1007/s12022-009-9072-4 · Cited by 50
K-ras-2 Topographic Genotyping of Pancreatic Adenocarcinoma
Finkelstein, S. D. (1994) · Archives of Surgery · doi:10.1001/archsurg.1994.01420280037005 · Cited by 38
Yachida, S., Zhong, Y., Pătrașcu, R., Davis, M. B., Morsberger, L. A., Griffin, C. A., Hruban, R. H., Laheru, D. A., & Iacobuzio–Donahue, C. A. (2011) · Pancreas · doi:10.1097/mpa.0b013e3182207a58 · Cited by 26
Self-citation
Cited by
Overview of the 2022 WHO Classification of Neuroendocrine Neoplasms
Rindi, G., Mete, O., Uccella, S., Basturk, O., La Rosa, S., Brosens, L. A. A., Ezzat, S., de Herder, W. W., Klimstra, D. S., Papotti, M., et al. (2022) · Endocrine Pathology · doi:10.1007/s12022-022-09708-2 · Cited by 1,036
Self-citationBasturk, O., Hong, S.-M., Wood, L. D., Adsay, N. V., Albores-Saavedra, J., Biankin, A. V., Brosens, L. A. A., Fukushima, N., Goggins, M., Hruban, R. H., et al. (2015) · American Journal of Surgical Pathology · doi:10.1097/pas.0000000000000533 · Cited by 864
Self-citationNeuroendocrine and Adrenal Tumors, Version 2.2021, NCCN Clinical Practice Guidelines in Oncology
Shah, M. H., Goldner, W. S., Benson, A. B., Bergsland, E., Blaszkowsky, L. S., Brock, P., Chan, J., Das, S., Dickson, P. V., Fanta, P., et al. (2021) · Journal of the National Comprehensive Cancer Network · doi:10.6004/jnccn.2021.0032 · Cited by 619
Garcia-Carbonero, R., Sorbye, H., Baudin, E., Raymond, E., Wiedenmann, B., Niederle, B., Sedlackova, E., Toumpanakis, C., Anlauf, M., Cwikla, J. B., et al. (2016) · Neuroendocrinology · doi:10.1159/000443172 · Cited by 611
Basturk, O., Yang, Z., Tang, L. H., Hruban, R. H., Adsay, V., McCall, C. M., Krasinskas, A. M., Jang, K.-T., Frankel, W. L., Balci, S., et al. (2015) · American Journal of Surgical Pathology · doi:10.1097/pas.0000000000000408 · Cited by 482
Self-citation
Metadata
- Authors
- Yachida, S., Vakiani, E., White, C. M., Zhong, Y., Saunders, T., Morgan, R., de Wilde, R. F., Maitra, A., Hicks, J., DeMarzo, A. M., Shi, C., Sharma, R., Laheru, D., Edil, B. H., Wolfgang, C. L., Schulick, R. D., Hruban, R. H., Tang, L. H., Klimstra, D. S., & Iacobuzio-Donahue, C. A.
- Venue
- American Journal of Surgical Pathology
- Published
- 2012-02
- Volume
- 36
- Issue
- 2
- Pages
- 173-184
- ISSN
- 0147-5185 (ISSN-L)
- OpenAlex
- W2023163806
- Cited by
- 534
- References
- 41
- FWCI
- 24.13
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.